Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors

Impact of Sitagliptin on Carotid Intima-Media Thickness in Patients With Coronary Artery Disease and Impaired Glucose Tolerance or Mild Diabetes Mellitus

(2014) Shinji Ishikawa et al.   AMERICAN JOURNAL OF CARDIOLOGY

Chronic Dipeptidyl Peptidase-4 Inhibition With Sitagliptin Is Associated With Sustained Protection Against Ischemic Left Ventricular Dysfunction in a Pilot Study of Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

(2014) Liam M. McCormick et al.   Circulation-Cardiovascular Imaging

Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis—evaluations in vitro and in the rat critical limb ischemia model

(2013) Sarah Chua et al.   CYTOTHERAPY

Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury

(2013) Yen-Ta Chen et al.   Stem Cell Research & Therapy

Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells

(2012) Chun-Yao Huang et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice

(2012) Junichi Matsubara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction

(2011) Yen-Ta Chen et al.   Journal of Translational Medicine

Infection-Related Hospitalizations in Older Patients With ESRD

(2010) Lorien S. Dalrymple et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Acute Kidney Injury in a Chinese Hospitalized Population

(2010) Yi Fang et al.   BLOOD PURIFICATION

Mobilized Human Hematopoietic Stem/Progenitor Cells Promote Kidney Repair After Ischemia/Reperfusion Injury

(2010) Bing Li et al.   CIRCULATION

Dipeptidylpeptitase-4 Inhibitors (Gliptins)

(2010) André J. Scheen   CLINICAL PHARMACOKINETICS

The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1 

(2010) G. P. Fadini et al.   DIABETES CARE

Acute Kidney Injury Associates with Increased Long-Term Mortality

(2009) J.-P. Lafrance et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

CKD Prevention in Sub-Saharan Africa: A Call for Governmental, Nongovernmental, and Community Support

(2008) Fatiu A. Arogundade et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction

(2008) Chirag R. Parikh et al.   ARCHIVES OF INTERNAL MEDICINE